CRISPR/Cas9-mediated genome editing in Ganoderma lucidum: recent advances and biotechnological opportunities
World Journal of Microbiology and Biotechnology · 2025
DOI: 10.1007/s11274-025-04458-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift World Journal of Microbiology and Biotechnology, 2025. Verfasst von Dongmei Lv und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, 650500, China. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, Reishi, Biotechnology. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Ganoderma lucidum is a well-known traditional medicinal mushroom that has attracted considerable attention due to its potential as a promising cell factory for producing high-value bioactive compounds. However, conventional methods for the genetic manipulation of G. lucidum are often time-consuming and labor-intensive, hindering research into the biosynthesis and regulatory mechanisms of its valuable natural products. In recent years, the clustered regularly interspaced short palindromic repeats/CRISPR-associated nuclease 9 (CRISPR/Cas9) system has emerged as a powerful genome editing tool, extensively utilized in life sciences research due to its high efficiency and user-friendliness. This review provides a structured overview of advancements in CRISPR/Cas9-mediated genome editing technology in G. lucidum. We first discuss the development and optimization of the CRISPR system, focusing on the various expression strategies for Cas9 and guide RNA established in G. lucidum. Furthermore, we highlight the application of this system for targeted gene deletion, insertion, and replacement in genome editing, as well as its use in the functional analysis of genes in G. lucidum. In addition, we discuss the limitations and challenges associated with employing CRISPR/Cas9 tools in G. lucidum and provide an outlook on the future development of the CRISPR/Cas9 system and its applications in this organism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, 650500, China.
- Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, 650500, China. jwxu@kust.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Lv, D., Xu, Y., Wang, Z. X., Zhang, Q. L., Yan, J. P., & Xu, J. W. (2025). CRISPR/Cas9-mediated genome editing in Ganoderma lucidum: recent advances and biotechnological opportunities. World Journal of Microbiology and Biotechnology. https://doi.org/10.1007/s11274-025-04458-9
Vancouver
Lv D, Xu Y, Wang ZX, Zhang QL, Yan JP, Xu JW. CRISPR/Cas9-mediated genome editing in Ganoderma lucidum: recent advances and biotechnological opportunities. World Journal of Microbiology and Biotechnology. 2025. doi:10.1007/s11274-025-04458-9
BibTeX
@article{Lv2025,
author = {Lv, Dongmei and Xu, Yan and Wang, Zi-Xu and Zhang, Qi-Lin and Yan, Jin-Ping and Xu, Jun-Wei},
title = {CRISPR/Cas9-mediated genome editing in Ganoderma lucidum: recent advances and biotechnological opportunities},
journal = {World Journal of Microbiology and Biotechnology},
year = {2025},
doi = {10.1007/s11274-025-04458-9}
}
EUVIMED